These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 8808714

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Streptococcus pyogenes: penicillin and erythromycin susceptibility in the cities of Neuquen and Cipolletti].
    Soriano SV, Brasili S, Saiz M, Carranza C, Vidal P, Calderón J, Lopardo HA.
    Medicina (B Aires); 2000; 60(4):487-90. PubMed ID: 11188957
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
    Gattringer R, Sauermann R, Lagler H, Stich K, Buxbaum A, Graninger W, Georgopoulos A.
    Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
    [Abstract] [Full Text] [Related]

  • 7. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro.
    Van Asselt GJ, Sloos JH, Mouton RP, Van Boven CP, Van de Klundert JA.
    J Med Microbiol; 1995 Nov; 43(5):386-91. PubMed ID: 7563004
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Incidence of erythromycin resistance in Streptococcus pyogenes: a 10-year study.
    Betriu C, Casado MC, Gómez M, Sanchez A, Palau ML, Picazo JJ.
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):255-60. PubMed ID: 10212752
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Activity of ceftibuten, cefaclor, azithromycin, clarithromycin, erythromycin and telithromycin against Streptococcus pyogenes clinical isolates with different genotypes and phenotypes.
    Drago L, Ripa S, Zampaloni C, De Vecchi E, Vitali LA, Petrelli D, Prenna M.
    Chemotherapy; 2005 Aug; 51(5):268-71. PubMed ID: 16088124
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group.
    Varaldo PE, Debbia EA, Nicoletti G, Pavesio D, Ripa S, Schito GC, Tempera G.
    Clin Infect Dis; 1999 Oct; 29(4):869-73. PubMed ID: 10589905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.